In most cases, however, the payer's response does not include the specific Service Type Codes (STC) needed to match the insurance benefit to the patient's clinical procedure. As a result, provider staff must analyze the payer data down to the plan level and specific STCs - a time-consuming task that hospitals often lack the resources to undertake, making it impossible to generate accurate estimates for most patients.
Recondo's BenefitsPlus™ solution automates that resource-intensive step, working in the background to complete the estimation process by adding built-in logic matching procedures with STCs. The process is enabled by Recondo's patented[i] Reconbot® technology, which takes the revenue cycle to the next level by automatically querying payer websites and then retrieving, normalizing and presenting information critical to the patient access and claims follow-up process.
With the combined solutions, end-users can now generate highly accurate estimates of patient financial responsibility for all procedures, without ever leaving the Epic system.
Case Study Available
To download a case study detailing one health system's use of the Epic-Recondo solution, visit http://www.recondotech.com/discover/resources/.
About Recondo Technology
Recondo's cloud-based solutions deliver financial clarity to all participants within the healthcare revenue cycle. Named the No. 1 hottest company in healthcare by Modern Healthcare in 2013 and a Cool Vendor for Healthcare Providers 2015 by Gartner, Recondo empowers more than 900 hospitals and health systems with solutions that connect providers with over 90% of the nation's payers and their patients to ensure proper and accelerated payments across the care continuum. The company's software and expertise streamline operations and achieve efficiencies and cost savings from patient access through claim status to payment processing-a continuum today where inaccuracy and inefficiencies currently cost U.S. healthcare a staggering $480 billion per year. Visit us at www.recondotech.com.
Back to HCB News
